-+ 0.00%
-+ 0.00%
-+ 0.00%

NOVOCURE’S OPTUNE PAX® RECEIVES CE MARK FOR THE TREATMENT OF LOCALLY ADVANCED PANCREATIC CANCER

Reuters·06/30/2026 11:00:00

Please log in to view news